Astec Lifesciences Stock

Astec Lifesciences Debt 2024

Astec Lifesciences Debt

4,914.62 INR

Ticker

ASTEC.NS

ISIN

INE563J01010

In 2024, Astec Lifesciences's total debt was 4,914.62 INR, a 76.27% change from the 2,788.2 INR total debt recorded in the previous year.

Astec Lifesciences Aktienanalyse

What does Astec Lifesciences do?

Astec Lifesciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Astec Lifesciences's Debt Structure

Astec Lifesciences's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Astec Lifesciences's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Astec Lifesciences’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Astec Lifesciences’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Astec Lifesciences stock

What is the debt of Astec Lifesciences this year?

Astec Lifesciences has a debt level of 4,914.62 INR this year.

What was the debt of Astec Lifesciences compared to the previous year?

The debt of Astec Lifesciences has increased by 76.27% compared to the previous year increased.

What are the consequences of high debt for investors in Astec Lifesciences?

High debt can pose a risk for investors of Astec Lifesciences, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Astec Lifesciences?

Low debt means that Astec Lifesciences has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Astec Lifesciences affect the company?

An increase in debt of Astec Lifesciences can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Astec Lifesciences affect the company?

A reduction in debt of Astec Lifesciences can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Astec Lifesciences?

Some factors that can influence the debt of Astec Lifesciences include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Astec Lifesciences so important for investors?

The debts of Astec Lifesciences are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Astec Lifesciences take to change the debt?

To change the debt, Astec Lifesciences can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Astec Lifesciences pay?

Over the past 12 months, Astec Lifesciences paid a dividend of 1.5 INR . This corresponds to a dividend yield of about 0.14 %. For the coming 12 months, Astec Lifesciences is expected to pay a dividend of 0.34 INR.

What is the dividend yield of Astec Lifesciences?

The current dividend yield of Astec Lifesciences is 0.14 %.

When does Astec Lifesciences pay dividends?

Astec Lifesciences pays a quarterly dividend. This is distributed in the months of August, August, August, August.

How secure is the dividend of Astec Lifesciences?

Astec Lifesciences paid dividends every year for the past 3 years.

What is the dividend of Astec Lifesciences?

For the upcoming 12 months, dividends amounting to 0.34 INR are expected. This corresponds to a dividend yield of 0.03 %.

In which sector is Astec Lifesciences located?

Astec Lifesciences is assigned to the 'Commodities' sector.

Wann musste ich die Aktien von Astec Lifesciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Astec Lifesciences from 8/1/2023 amounting to 1.5 INR, you needed to have the stock in your portfolio before the ex-date on 7/21/2023.

When did Astec Lifesciences pay the last dividend?

The last dividend was paid out on 8/1/2023.

What was the dividend of Astec Lifesciences in the year 2023?

In the year 2023, Astec Lifesciences distributed 1.5 INR as dividends.

In which currency does Astec Lifesciences pay out the dividend?

The dividends of Astec Lifesciences are distributed in INR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Astec Lifesciences

Our stock analysis for Astec Lifesciences Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Astec Lifesciences Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.